CAP'Onco : Psychological and Social Consultation of Professional Accompaniment in Oncology

Study Overview
=================
Brief Summary
-----------------
This patient support system is designed to help patients regain their professional activity after their treatment. It's a 3-Axis neuropsycho-social synergy on 3 axes: A weekly pluridisciplinary consultation in tandem (Social worker + Psychologist / Neuropsychologist) Monthly information meetings and workshops (TIC'Onco reunions: collective information times and Cogit'Onco workshops: cognitive workshops An information booklet Prepare the work return The aim of this research is to evaluate efficiency in term of quality of life improvement linked to work status, utility, feasibility and patients' satisfaction. The aim of this research is to evaluate efficiency in term of quality of life improvement linked to work status, utility, feasibility and patients' satisfaction.

Detailed Description
-----------------
Unmet need characterize in 4 points: Cancer and survival: challenges for cancer patients who want to work while being treated Cancer and career: Job instability for cancer patients Difficulties and isolation of patients due to a lack of coordination between healthcare professionals and colleagues/management Post-treatment cognitive troubles stress and hindered patient return to employment: chemo brain This research-action will propose and evaluate a concrete device: To maintain a professional activity with the support of CAP'Onco during treatment, to balance between quality of life, managing the cancer event and the psychosocial consequences for professional experience, to provide an early, durable and multimodal support to improve work keeping and anticipate return to employment

Official Title
-----------------
CAP'Onco : Psychological and Social Consultation of Professional Accompaniment in Oncology

Conditions
-----------------
Cancer

Intervention / Treatment
-----------------
* Other: Psychological and Social Consultation


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Patients attending the Institut Bergonié Informed Consent signed. Patients affiliated to a French social living in Gironde Professional activity at the time of diagnosis Treated for - breast cancer, Hodgkin's or non-Hodgkin's lymphoma (non-cerebral), testicular cancer CURATIVE support At any time during treatment (chemotherapy or radiotherapy, or immunotherapy) Exclusion Criteria: Patient deprived of liberty or subject to a legal protection measure History of cancers Cerebral pathology and / or brain metastasis

Ages Eligible for Study
-----------------
Minimum Age: 25 Years
Maximum Age: 55 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Design Details

Primary Purpose: Supportive Care
Intervention Model: Single Group Assignment
Interventional Model Description: Prospective study
Masking: None (Open Label)


Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Experimental: Psychological and Social Consultation<br>Psychological and Social Consultation | Other: Psychological and Social Consultation<br>* Psychological and Social Consultation at Baseline, during the study and at the end of follow-up<br>|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Quality of Life : EORTC QLQ-C30 Scores | Standardised QLQ-C30 scoring according to EORTC scoring manual (Fayers et al. EORTC QLQ-C30 scoring manual. 2001). 15 dimensions are presented below. Each dimension is a standardised score ranges from 0 to 100. A low score corresponds to a low functional level, an absence of symptoms or a low level of QoL/ overall health and, conversely, so that a high score corresponds to a high functional level, a high presence of symptoms or a high level of QoL/overall health. | At baseline and 5 months | 
| Cognitive Complaints : FACT Cog Scale Scores | Cognitive complaints were evaluated by using the french Functional Assessment of Cancer Therapy-Cognitive Function (FACT-Cog) scale version 3 Assessed using median total score (range 0-132) and median scores of these 4 dimensions : Perceived Cognitive Impairment (range 0-72) Impact on quality of life (range 0-16) Comments from others (range 0-16) Perceived Cognitive Skills (range 0-28) Higher scores indicate better cognitive functioning. | At baseline and 5 months | 
| Professional Recovery Scale Scores | Professional recovery was evaluated by using the Scale of motivation to Professional recovery. This scale was constructed for the needs of this exploratory research and has for vocation a later validation. It includes 62 questions and was assessed using median scores of these 7 dimensions : Work and administrative process (0-100) Positioning in relation to the job-post-mission (0-100) Emotion and work (0-100) Labour relations (0-100) Work and physical/intellectual conditions (0-100) Privacy and work (0-100) Return to work (0-20) Higher scores represent better outcomes | At baseline and 5 months | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Tiredness : Piper MFI-20 Scale Scores | Tiredness was evaluated by using the Piper Multidimensional Fatigue Inventory (MFI-20) revised scale Assessed using median total score (range 0-10) and median scores of these 4 tiredness dimensions : Behavioural Emotional Sensory Cognitive-mood Each dimension has range 0-10 with following interpretation: higher scores indicate greater severity of fatigue | At baseline and 5 months | 
| Anxio-depressive Troubles : HAD Scale Scores | Anxio-depressive troubles were evaluated by using the Hospital Anxiety and Depression (HAD) scale. Assessed using median scores of these 2 dimensions : Anxiety Depression Each dimension has range 0-21 with following interpretation: higher scores represent worse outcomes (0-7 normal; 8-10 mild; 11-14 moderate; 15-21 severe) | At baseline and 5 months | 

 Terms related to the study
=================
Keywords Provided by Centre Hospitalier Valida
-----------------
Oncology, Work Keeping, Social difficulties, Cognitive Disorders